It has long been noted that rates of IBD increase as nations develop. What drives this increase in “developing” nations, and what factors keep inflammatory bowel disease (IBD) rates high in the West? Gilaad G. Kaplan, MD, of the Department of Medicine, University of Calgary, discusses the epidemiological stages of IBD and reviews how disease
Individuals with inflammatory bowel disease had a 4.1% increased incidence of dementia
Miguel Regueiro, MD, chair of the Department of Gastroenterology, Hepatology and Nutrition at the Cleveland Clinic, discusses how to position therapies for the treatment of inflammatory bowel disease.
Patients with both Clostridiodes difficile infection and inflammatory bowel disease showed improvement after fecal microbiota transplantation, Jessica Allegretti, MD, director of the FMT program at Brigham and Women’s Hospital, said during a presentation at Digestive Disease Week. The ICON study took place at four sites across the US. Results for FMT in C. dif alone
Nearly all women who were diagnosed with inflammatory bowel disease reported sexual problems, according to a study at the University of Minnesota that was published in Inflammatory Bowel Diseases. Scores were similar for patients with Crohn’s disease and ulcerative colitis. Surprisingly, remission of disease did not alleviate the symptoms, according to the study. “This is
Patients with inflammatory bowel disease and GI cancers were more likely to get vaccinations such as flu shots after a consultation with a health care provider, according to a study published in Alimentary Pharmacology & Therapeutics. IBD and GI cancer patients have a high risk of contracting flu or pneumococcus, but the vaccination rate is
According to a study in Inflammatory Bowel Diseases, patients with inflammatory bowel disease often struggle with body image and sexuality and this could lead to sexual dysfunction. Men with IBD who were younger than 50 and women younger than 40 had a significantly increased risk, the study said. “Inflammatory bowel disease could have a major
An estimated 30-50%, and possible 60%, of patients with inflammatory bowel disease (IBD) turn to complementary and alternative medicines (CAM’s) to ease symptoms and exert more control over their treatment. Very few studies have evaluated CAM’s, and many of the studies were small, poorly designed, and uncontrolled. Predictors of CAM use include dissatisfaction with conventional therapies,
Almost 1 in 5 patients with symptomatic inflammatory bowel disease also had non-Clostridium difficile enteric infection, according to a study published in The American Journal of Gastroenterology. Although the infections had an effect on treatment, there was no long-term effect. See the article on MedPage Today here.
Dr. Jonathan Kay of the University of Massachusetts Medical School told the 2018 Interdisciplinary Autoimmune Summit that biosimilar competition in Europe has reduced drug costs, made biosimilars more available and increased market share for some bio-originators. The European Union has approved 41 biosimilar drugs while the FDA has approved nine. Biosimilars in Europe lead to
